Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT06717828 Sponsor: Fujian Provincial Hospital Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT06717828
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 40 and 75 years old
  • A scan has shown that your liver contains 5% or more fat
  • You have been diagnosed with fatty liver disease linked to metabolic health problems (sometimes called MAFLD or metabolic-associated fatty liver disease)
  • You are overweight or obese, with a BMI of 24 or higher
  • You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • You drink a large amount of alcohol regularly — specifically, more than 140g of alcohol per week if male, or more than 70g per week if female, in the past 6 months
  • Your fatty liver is caused by something other than metabolic issues, such as alcohol, a viral infection, medication, or an autoimmune condition
  • You have had a serious heart event, such as a heart attack, in the past 6 months
  • You have moderate to severe heart failure that significantly limits your daily activities
  • You have a blockage or disease affecting your bile ducts
  • You have a condition that affects how your body handles blood sugar or fats, such as diabetes, an overactive or underactive thyroid, or Cushing's syndrome
  • Your blood pressure is very high and not well controlled (top number 180 or above, or bottom number 100 or above)
  • You have chronic kidney disease or significantly reduced kidney function (confirm with trial site for exact values)
  • You have dementia or a cognitive condition that makes normal communication difficult
  • You are currently pregnant or planning to become pregnant soon
  • You have any other condition that would prevent you from attending follow-up appointments or completing the programme
  • You are unable to take part in exercise — for example, due to severe pain, joint problems, or because you are taking certain medications such as steroids, liver medications, or drugs that affect your heart rate like beta-blockers

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fujian Provincial Hospital
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Determination of Liver Fat Content

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov